SCHEMBL13047142

SCHEMBL13047142

Cc1cccc(C(=O)Nc2cccc3c(=O)n(C)ccc23)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.50
MAOB P27338 3/20 0.48
NPC1 O15118 5/20 0.48
RAB9A P51151 5/20 0.48
HSD17B10 Q99714 3/20 0.48
LMNA P02545 2/20 0.48
TP53 P04637 2/20 0.48
HTT P42858 2/20 0.48
TSHR P16473 1/20 0.48
ALDH1A1 P00352 4/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
MCL1 Q07820 1/20 0.42
POLB P06746 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13047468 0.91 PARP1 (0.60) PARP1MAOBNPC1RAB9AHSD17B10
SCHEMBL13047469 0.83 POLB (0.46) PARP1MAOBRAB9AHSD17B10LMNA
SCHEMBL13046840 0.82 PARP1 (0.43) PARP1MAOBNPC1RAB9AHSD17B10
SCHEMBL1591452 0.81 PARP1 (0.44) PARP1MAOBNPC1RAB9AHSD17B10
SCHEMBL1590151 0.81 P2RX7 (0.56) PARP1MAOBNPC1RAB9AHSD17B10
SCHEMBL13046922 0.79 SMN1; SMN2 (0.46) MAOBNPC1RAB9AALDH1A1MAPT
SCHEMBL13047642 0.78 CCR8 (0.43) PARP1MAOBNPC1RAB9AHSD17B10
SCHEMBL13587424 0.78 NPC1 (0.43) PARP1MAOBNPC1RAB9AHSD17B10
SCHEMBL13047183 0.77 MRGPRX1 (0.45) PARP1RAB9ATSHRALDH1A1MAPT
SCHEMBL1590675 0.77 CCR8 (0.41) PARP1MAOBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-8546579-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof EVOTEC (US) INC. (US) 2013-10-01 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof SECOND GENOME, INC. 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292235-A1 Bicycloheteroaryl Compounds as P2x7 Modulators and Uses Thereof P2RX7, P2RX3, P2RX2 PARP1 1754/4885MAOB 1873/4885NPC1 2233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.